Cerebellar dysfunction in patients with bronchogenic carcinoma: immunological investigations
- 1 May 1988
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 235 (5), 297-299
- https://doi.org/10.1007/bf00314177
Abstract
Sera from seven patients with bronchogenic carcinoma and cerebellar dysfunction were tested for anti-Purkinje cell antibodies (APCA) by indirect immunofluorescence and indirect immunoperoxidase reaction. Specific APCA as described in paraneoplastic cerebellar degeneration (PCD) were not detected in any of these patients or in control patients. The lack of APCA in patients with bronchogenic carcinoma and their presence in association with ovarian or breast cancer indicate that different pathogenetic mechanisms may play a role in PCD.Keywords
This publication has 10 references indexed in Scilit:
- Cerebellar dysfunction in patients with bronchogenic carcinoma: clinical and posturographic findingsZeitschrift für Neurologie, 1988
- Antibodies to brain proteins in paraneoplastic cerebellar degenerationNeurology, 1986
- Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degenerationNeurology, 1986
- Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigenAnnals of Neurology, 1985
- Neuronal antinuclear antibody in sensory neuronopathy from lung cancerNeurology, 1985
- Temporal lobe encephalocelesNeurology, 1985
- Lambert-Eaton myasthenic syndrome.1985
- Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinomaAnnals of Neurology, 1983
- Cerebellar cortical degeneration with ovarian carcinomaPostgraduate Medical Journal, 1982
- Cerebellar Degeneration With Hodgkin DiseaseArchives of Neurology, 1976